Chronic Grape Extract in Crosstraining Athletes: A Randomized Crossover Trial
ConditionPerformance
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18-35
SponsorUniversidad de Granada
About this trial
The aim of this study is to investigate the effect of cronic GSE intake in crosstraining may have a favorable impact on biochemical markers, recovery, and performance.
Eligibility criteria
Qualifiers
Age: 18-35 years.
Body mass index: 18.5-30 kg/m2.
Ability to understand the instructions, objectives, and study protocol.
Minimum of 3 years of experience in crosstraining, with at least 6 hours of weekly training over the past 3 months.
Disqualifiers
History of a significant adverse cardiovascular event, renal insufficiency, cirrhosis, eating disorder, weight control surgical intervention, or type 2 diabetes mellitus.
Any chronic pathology in which the intake of nutritional supplements, especially use of antioxidant supplements during the 4 weeks prior to the start of the study.
Any condition that, in the investigator's judgment, would impair the ability to participate in the study or represent a personal risk to the participant.
Use of medications that may affect the study results.
Trial design
Treatments tested in this trial
- Grape Seed Extract
- Placebo
Treatment groups
30 Participants
are divided into 2 treatment groupsLocations
1Universidad de la Laguna Santa Cruz de Tenerife Spain
Sponsors and collaborators
Universidad de Granada
Lead sponsor
Universidad de La Laguna, San Cristóbal de La Laguna, Santa Cruz de Tenerife, Spain.
Collaborator
Source ClinicalTrials.gov